10 reports

  • GLOBAL BIOTECHNOLOGY MARKET BREAKDOWN BY TECHNOLOGY, 2017 & 2025 (%)
  • INDIA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

Cancer is one of the major cause of death.

  • Molecular Diagnostics
  • World
  • Forecast
  • Market Size
  • Agilent Technologies, Inc.

This advancement can be accounted to the emergence of different fields of medical sciences like proteomics, genomics, nucleic acid testing technology and nanobiotechnology.

  • Bioproduct
  • Molecular Diagnostics
  • Surgery
  • China
  • Demand

THIS ADVANCEMENT CAN BE ACCOUNTED TO THE EMERGENCE OF DIFFERENT FIELDS OF MEDICAL SCIENCES LIKE PROTEOMICS, GENOMICS, NUCLEIC ACID TESTING TECHNOLOGY AND NANOBIOTECHNOLOGY.

  • Molecular Diagnostics
  • Surgery
  • China
  • Demand
  • Supply
  • 2. United States Molecular Diagnostics Market & Forecast

Further, the applications of different technologies like genomics, proteomics, nanobiotechnology, pharmacogenomics, etc are driving innovation within this market.

  • Molecular Diagnostics
  • North America
  • United States
  • bioMerieux S.A.
  • Cepheid
  • 2. Global Molecular Diagnostics Market and Forecast (2010 - 2021)

Note: ##.

  • Molecular Diagnostics
  • bioMerieux S.A.
  • Cepheid
  • Hologic, Inc.
  • Myriad Genetics, Inc.

UCD offers inter-institutional collaborative programs and research centers in the areas which include sensor web technologies, systems biology and nanobiotechnology and biopharmaceuticals, among others.

  • Healthcare
  • Molecular Diagnostics
  • Prostate Cancer
  • Surgery
  • bioMerieux S.A.

NANOBIOTECHNOLOGY JOINS THE BREAKTHROUGHS IN NANOTECHNOLOGY TO THOSE IN MOLECULAR BIOLOGY.

  • Molecular Diagnostics
  • Surgery
  • Market Size
  • Amgen Inc.
  • Merck & Co., Inc.
  • 3.7 PATENT TRENDS

New area of research called nanobiotechnology has also emerged.

  • Surgery
  • World
  • Market Size
  • DePuy Synthes, Inc.
  • DJO
  • 2.1 United States - Molecular Diagnostics Market and Forecast

Note: ##.

  • Molecular Diagnostics
  • Cepheid
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • Roche Group

IS A PRIVATELY HELD NANOBIOTECHNOLOGY COMPANY DEDICATED TO COMMERCIALIZATION OF SELF-ILLUMINATING RED TO NEAR INFRARED (NIR) EMITTING NANOCRYSTAL TECHNOLOGIES FOR PRECLINICAL IN VIVO IMAGING AND AS AN ANALYTICAL PLATFORM FOR MOLECULAR DETECTION.

  • Molecular Diagnostics
  • Pharmaceutical
  • United States
  • M&A
  • Life Technologies Corporation